Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna Liquid
NDC 43742-2105
View dosage, usage, ingredients, routes, and UNII mappings.
Product Information
This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.
Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna is a DRUG FOR FURTHER PROCESSING-approved product labeled by Deseret Biologicals, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a liquid. This product entry covers the primary NDC 43742-2105 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
NDC Product Code:
43742-2105
Proprietary Name:
Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna
Non-Proprietary Name: [1]
Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna
Substance Name: [2]
Bartonella Bacilliformis; Bartonella Bacilliformis Dna; Bartonella Clarridgeiae; Bartonella Clarridgeiae Dna; Bartonella Elizabethae; Bartonella Henselae; Bartonella Henselae Dna; Bartonella Quintana; Bartonella Quintana Dna; Bartonella Vinsonii; Bartonella Vinsonii Dna; Bartonella Washoensis; Bartonella Washoensis Dna; Herring Sperm Dna
NDC Directory Status:
Drug For Further Processing
Product Type: [3]
UNFINISHED PRODUCT INCLUDED in the NDC Directory
Code Navigator:
Clinical Specifications
Dosage Form:
Liquid
- A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Labeler & Regulatory Data
Labeler Name: [5]
Labeler Code:
43742
Marketing Category: [8]
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Marketing Timeline
Start Marketing Date: [9]
12-13-2023
End Marketing Date: [10]
11-15-2028
Exclude Flag: [12]
N
Unfinished Product: [13]
Yes
Code Structure Chart
Product Details
What is NDC 43742-2105?
The NDC code 43742-2105 is assigned by the FDA to the product Bartonella Bacilliformis, Bartonella Clarridgeiae, Bartonella Elizabethae, Bartonella Henselae, Bartonella Quintana, Bartonella Vinsonii, Bartonella Washoensis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae Dna, Bartonella Elizabethae Dna, Bartonella Henselae Dna, Bartonella Quintana Dna, Bartonella Vinsonii Dna, Bartonella Washoensis Dna. It is commonly known by its generic name, bartonella bacilliformis, bartonella clarridgeiae, bartonella elizabethae, bartonella henselae, bartonella quintana, bartonella vinsonii, bartonella washoensis, bartonella bacilliformis dna, bartonella clarridgeiae dna, bartonella elizabethae dna, bartonella henselae dna, bartonella quintana dna, bartonella vinsonii dna, bartonella washoensis dna. This pharmaceutical product is labeled by Deseret Biologicals, Inc. and is currently categorized as listed product. The medication is a liquid. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 43742-2105-1. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.
What are Active Ingredients of this product?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
- BARTONELLA BACILLIFORMIS 200 [hp_X]/mL - The type species of the genus BARTONELLA, a gram-negative bacteria found in humans. It is found in the mountain valleys of Peru, Ecuador, and Southwest Columbia where the sandfly (see PHLEBOTOMUS) vector is present. It causes OROYA FEVER and VERRUGA PERUANA.
- BARTONELLA BACILLIFORMIS DNA 200 [hp_X]/mL
- BARTONELLA CLARRIDGEIAE 200 [hp_X]/mL
- BARTONELLA CLARRIDGEIAE DNA 200 [hp_X]/mL
- BARTONELLA ELIZABETHAE 200 [hp_X]/mL
- BARTONELLA HENSELAE 200 [hp_X]/mL - A species of gram-negative bacteria that is the etiologic agent of bacillary angiomatosis (ANGIOMATOSIS, BACILLARY). This organism can also be a cause of CAT-SCRATCH DISEASE in immunocompetent patients.
- BARTONELLA HENSELAE DNA 200 [hp_X]/mL
- BARTONELLA QUINTANA 200 [hp_X]/mL - A species of gram-negative bacteria in which man is the primary host and the human body louse, Pediculus humanus, the principal vector. It is the etiological agent of TRENCH FEVER.
- BARTONELLA QUINTANA DNA 200 [hp_X]/mL
- BARTONELLA VINSONII 200 [hp_X]/mL
- BARTONELLA VINSONII DNA 200 [hp_X]/mL
- BARTONELLA WASHOENSIS 200 [hp_X]/mL
- BARTONELLA WASHOENSIS DNA 200 [hp_Q]/mL
- HERRING SPERM DNA 200 [hp_X]/mL
* Please review the full disclaimer at the bottom of this page.
Product & Regulatory Definitions
What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
What is the Substance Name? An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
What kind of product is this? Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the End Marketing Date? This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".
What is an Unfinished Product? This field indicates if the product is an unfinished drug. An unfinished drug is an active pharmaceutical ingredient either alone or with other ingredients that is not a finished drug product. Unfinished drugs are used to process other drugs or for drug compounding.
